Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer
Clinical trial NCT04004221 · COMPLETED
Trial details
- NCT number
- NCT04004221
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-16
- Primary completion
- 2019-09-16
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.